|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/436 | |
| A61K 31/5377 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Number of the document | 2370076 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09756528.7 |
| Date of filing the European patent application | 2009-11-25 | |
| (97) | Date of publication of the European application | 2011-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/065858 |
| Date | 2009-11-25 |
| (87) | Number | WO 2010/060937 |
| Date | 2010-06-03 |
| (30) | Number | Date | Country code |
| 08170279 | 2008-11-28 | EP | |
| 08170287 | 2008-11-28 | EP | |
| 08170230 | 2008-11-28 | EP | |
| 08170246 | 2008-11-28 | EP |
| (72) |
JENSEN, Michael, Rugaard, CH
GARCIA-ECHEVERRIA, Carlos, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Pharmaceutical combination comprising a Hsp 90 inhibitor and a mTOR inhibitor |
| Pharmaceutical combination comprising a Hsp 90 inhibitor and a mTOR inhibitor |